Table 1 Clinical and biological data of the DBA patients

From: Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitro

DBA

Sex

Mode of inheritance

Age at diagnosis (month)

Hb at diagnosis (g/dl)

Absolute retic count (giga/l)

eADA (nmoles/min/mg)

Congenital malformations

Treatment at the time of the study

Genotype

1

F

Sporadic

NA

NA

NA

1.61

Hypogammaglobulinemia, short stature

IT

RPS19+/−

2

F

Sporadic

3

5.6

NA

3.6

Short stature, prognatism, low hair implantation

T

RPS19+/−

3

M

Sporadic

2

3.7

3

4.9

Epicanthus, low hair implantation

C

RPS19+/−

4

F

Sporadic

3.5

3.7

4

0.86

Short stature, surdity, hip dysplasia

T

RPS19+/−

5

M

Sporadic

NA

NA

NA

NA

Heart, bones, epilepsia, hydrocephaly

T

RPS19+/−

6

F

Familial

2

5

<20

Normal

No

NA

RPS19+/−

7

M

Familial

NA

NA

NA

NA

No

NA

RPS19+/−

8

M

Sporadic

1.5

4.2

595

NA

No

T

RPS19+/−

9

F

Sporadic

NA

NA

NA

NA

No

T

RPS19+/−

10

F

Sporadic

2

4.5

12.5

3

No

T

RPS19+/−

11

F

Sporadic

1

3.9

4.56

NA

Growth retardation

IT

RPS19+/−

12

F

Sporadic

2

4.2

2

NA

Diabetes, low implantation of the thumb

T

RPS19+/−

13

M

Sporadic

Birth

9.5

15

4.93

Spina bifida, dysimmunity, triphalangeal thumb

C

RPL11+/−

14

M

Sporadic

3

3.3

5

NA

Short stature, flat tenar

C

RPL11+/−

15

M

Sporadic

1

6.4

9

6.15

No

T

RPL11+/−

  1. Abbreviations: C, corticosteroids; eADA, erythrocyte adenosine deaminase; F, female; IT, treatment independence; M, male; NA, not available; T, transfusions.